Drug intelligence / Profile preview

histaglobulin

Development stage
Phase 4
Lead developer
Bharat Serums and Vaccines
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Histaglobulin is a sterile injectable preparation composed of human normal immunoglobulin (gamma globulin) coupled with a small amount of histamine dihydrochloride and sodium thiosulphate. It is used primarily for the prevention and treatment of various allergic conditions such as allergic rhinitis, eczema, urticaria (including chronic urticaria), generalized skin allergies, asthma, atopic dermatitis, and sometimes migraine. The drug works by inducing the production of antihistaminic antibodies that neutralize free histamine released during allergic reactions. This leads to a reduction in allergy symptoms over time. The mechanism involves stimulating an immune response against the histamine-immunoglobulin complex; repeated dosing increases antibody titers and can provide long-term remission from symptoms[1][2][3][4][5]. It is not recommended for use during acute allergic attacks or in certain populations such as pregnant women.

Brand names
HISTOGLOBHistobulin
Other names
histaglobinHistamine-fixed immunoglobulinHuman Normal Immunoglobulin + Histamine Dihydrochloride + Sodium Thiosulphate

Beyond the preview

Go deeper on histaglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on histaglobulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call